A strategic look at next-generation obesity therapeutics, oral GLP-1s, amylin analogs, and competitive dynamics in metabolic medicine.

A strategic look at longevity biotech, GLP-1s, healthspan science, wearables, and venture activity shaping the 2025 aging biology landscape.